Management of antithrombotic therapy in patients undergoing transcatheter aortic valve implantation: a consensus document of the ESC Working Group on Thrombosis and the European Association of Percutaneous Cardiovascular Interventions (EAPCI), in collaboration with the ESC Council on Valvular Heart Disease

J. ten Berg*, D. Sibbing, B. Rocca, E. Van Belle, B. Chevalier, J.P. Collet, D. Dudek, M. Gilard, D.A. Gorog, J. Grapsa, E.L. Grove, P. Lancellotti, A.S. Petronio, A. Rubboli, L. Torracca, G. Vilahur, A. Witkowski, J. Mehilli

*Corresponding author for this work

Research output: Contribution to journalEditorialAcademicpeer-review

21 Citations (Web of Science)
Original languageEnglish
Pages (from-to)2265-2269
Number of pages5
JournalEuropean Heart Journal
Volume42
Issue number23
DOIs
Publication statusPublished - 14 Jun 2021

Keywords

  • Transcatheter aortic valve implantation
  • Antithrombotic treatment
  • ANTIPLATELET THERAPY

Cite this